Skip to main content
Michael Rogawski, MD, Neurology, Sacramento, CA, UC Davis Medical Center

MichaelAndrewRogawskiMDPhD

Neurology • Sacramento, CA

Professor, School of Medicine, University of California, Davis

Join to view full profile

Dr. Rogawski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rogawski's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurology, 1984 - 1986
  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthResidency, Neurology, 1983 - 1984
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurology, 1982 - 1983
  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthResidency, Neurology, 1981 - 1982
  • Yale-New Haven Medical Center (Waterbury)
    Yale-New Haven Medical Center (Waterbury)Internship, Internal Medicine, 1980 - 1981
  • Yale School of Medicine
    Yale School of MedicineClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - 2025
  • MD State Medical License
    MD State Medical License 1982 - 2007

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • 15th Annual Meeting of American Society for Experimental NeuroTherapeutics: ASENT 2013 
    American Society for Experimental NeuroTherapeutics(ASENT), Bethesda, Maryland - 2/28/2013
  • Neurology Update 2012: Practical Information for the Primary Care Provider 
    UC Davis Health System, Sacramento, California - 5/19/2012

Press Mentions

  • Xenon Pharmaceuticals Announces Completion of Patient Randomization in XEN1101 Phase 2b “X-TOLE” Clinical Trial and Announces Upcoming Investor Webinar with Leading Epilepsy Key Opinion Leaders
    Xenon Pharmaceuticals Announces Completion of Patient Randomization in XEN1101 Phase 2b “X-TOLE” Clinical Trial and Announces Upcoming Investor Webinar with Leading Epilepsy Key Opinion LeadersJuly 7th, 2021
  • Neurologist Michael Rogawski Named Fellow of National Academy of Inventors
    Neurologist Michael Rogawski Named Fellow of National Academy of InventorsDecember 9th, 2020
  • Celebrating 20 Years
    Celebrating 20 YearsOctober 28th, 2020
  • Join now to see all

Grant Support

  • Training In Neurotherapeutics Discovery And Development For Academic ScientistsNational Institute Of Neurological Disorders And Stroke2012
  • Identification Of Novel Therapeutic Approaches For Tets And OP IntoxicationNational Institute Of Neurological Disorders And Stroke2010–2011
  • Ion Channels In Epilepsy And As Targets For AntiepileptiNational Institute Of Neurological Disorders And Stroke2001–2006
  • Evaluation Of Novel Epilepsy Treatment ApproachesNational Institute Of Neurological Disorders And Stroke1998–2006
  • Epilepsy: Ion Channels As Antiepileptic TargetsNational Institute Of Neurological Disorders And Stroke2004
  • Ion Channels In Epilepsy And Targets For AntiepilepticsNational Institute Of Neurological Disorders And Stroke2003
  • Ion Channels In Epilepsy And As Targets For Antiepileptic DrugsNational Institute Of Neurological Disorders And Stroke1998–2000
  • Preclinical Evaluation Of Novel Anticonvulsant DrugsNational Institute Of Neurological Disorders And Stroke1993–1997
  • Pharmacological Studies Of Ion Channels In Cultured CellsNational Institute Of Neurological Disorders And Stroke1993–1997

Professional Memberships

Hospital Affiliations

Dr. Michael Rogawski, Dr. Michael Rogawski, MD, Dr. M Rogawski, Dr. Michael Andrew Rogawski